Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Staszewski

Showing results (31-40 of 95) with videos related to

Pageof 10
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|September 15, 1990
Demonstration of cross-reactive antibodies able to elicit lysis of both HIV-1- and HIV-2-infected cellsS G Norley, U Mikschy, A Werner, et al.
Lancet (London, England)|February 16, 1999
Risk of new AIDS diseases in people on triple therapyV Miller, S Staszewski, G Nisius, et al.
Praxis Und Klinik Der Pneumologie|November 1, 1983
[Lymphomatoid granulomatosis. Presentation of 2 cases and description of significant symptoms]C M Freienstein, S Staszewski, H Müller, et al.
European Journal of Medical Research|November 19, 2002
Limited effect of food composition on the pharmacokinetics of nelfinavir administered twice dailyMichael Kurowski, B Kaeser, A Sawyer, et al.
AIDS (London, England)|February 24, 2001
The virological response to highly active antiretroviral therapy over the first 24 weeks of therapy according to the pre-therapy viral load and the weeks 4-8 viral loadA C Lepri, V Miller, A N Phillips, et al.
AIDS (London, England)|December 5, 1997
Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapyH R Brodt, B S Kamps, P Gute, et al.
MMW, Munchener Medizinische Wochenschrift|September 30, 1983
[Treatment of opportunistic infections in AIDS]S Staszewski, E B Helm, K H Nerger, et al.
HIV Medicine|August 15, 2006
A randomized, open-label study to compare the effects of two different doses of recombinant human growth hormone on fat reduction and fasting metabolic parameters in HIV-1-infected patients with lipodystrophyM Bickel, S Zangos, V Jacobi, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|November 1, 1991
Fluconazole prophylaxis of recurrent oral candidiasis in HIV-positive patientsG Just-Nübling, G Gentschew, K Meissner, et al.
Medizinische Klinik (Munich, Germany : 1983)|May 15, 1993
[Epidemiology of tuberculosis in patients with HIV infection of the Frankfurt University Clinic]H R Brodt, S Staszewski, R Enzensberger, et al.
Pageof 10

Showing results (31-40 of 95) with videos related to

Sort By:
Pageof 10
Journal of Immunology (Baltimore, Md. : 1950)|September 15, 1990
Demonstration of cross-reactive antibodies able to elicit lysis of both HIV-1- and HIV-2-infected cellsS G Norley, U Mikschy, A Werner, et al.
Lancet (London, England)|February 16, 1999
Risk of new AIDS diseases in people on triple therapyV Miller, S Staszewski, G Nisius, et al.
Praxis Und Klinik Der Pneumologie|November 1, 1983
[Lymphomatoid granulomatosis. Presentation of 2 cases and description of significant symptoms]C M Freienstein, S Staszewski, H Müller, et al.
European Journal of Medical Research|November 19, 2002
Limited effect of food composition on the pharmacokinetics of nelfinavir administered twice dailyMichael Kurowski, B Kaeser, A Sawyer, et al.
AIDS (London, England)|February 24, 2001
The virological response to highly active antiretroviral therapy over the first 24 weeks of therapy according to the pre-therapy viral load and the weeks 4-8 viral loadA C Lepri, V Miller, A N Phillips, et al.
AIDS (London, England)|December 5, 1997
Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapyH R Brodt, B S Kamps, P Gute, et al.
MMW, Munchener Medizinische Wochenschrift|September 30, 1983
[Treatment of opportunistic infections in AIDS]S Staszewski, E B Helm, K H Nerger, et al.
HIV Medicine|August 15, 2006
A randomized, open-label study to compare the effects of two different doses of recombinant human growth hormone on fat reduction and fasting metabolic parameters in HIV-1-infected patients with lipodystrophyM Bickel, S Zangos, V Jacobi, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|November 1, 1991
Fluconazole prophylaxis of recurrent oral candidiasis in HIV-positive patientsG Just-Nübling, G Gentschew, K Meissner, et al.
Medizinische Klinik (Munich, Germany : 1983)|May 15, 1993
[Epidemiology of tuberculosis in patients with HIV infection of the Frankfurt University Clinic]H R Brodt, S Staszewski, R Enzensberger, et al.
Pageof 10